ARCHIVES

Scope Of Panel’s Inquiry Outlined In Letter To Members

This article is from The Cancer Letter archive.

Vol. 20 No. 29 | July 22, 1994

Download PDF Visit The Full Archive

Related Articles

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

December 27, 2002

FDA Opponents Claim Abuses; Agency Doesn’t Attend Hearing

July 28, 1995

In Brief: Stephen Schimpff Accepts New Position Of Executive Vice President Of Univ. Of Maryland Medical System

October 4, 1985

NCCS Networker Volume 1 Issue 1, March 1987

March 12, 1987

NCI To Lose 19% of Workforce Over Six Years, Broder Says

November 4, 1994

Drug Shortages Prompt Doctors, Societies to Consider Non-Profit Pharma Company

September 9, 2011